Epigenetics are one of life's primary drivers of adaptations. They are why human beings who live at high altitude have more ...

Innovative research approaches are therefore urgently needed to achieve long-term progress in prevention and ...

BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an early-to-mid stage trial of its malaria vaccine.

BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...

"Our research shows that PfSnf2L is essential for P. falciparum to dynamically adjust gene expression," explains Maria Theresia Watzlowik, lead author of the study. "The unique sequence and ...

Press Release - Led by the Ministry of Health and with the support of Gavi, the Vaccine Alliance (Gavi), UNICEF, the World ...

The FDA’s clinical hold has prompted a cautious response from investors, reflecting the heightened regulatory scrutiny that BioNTech now faces. The company’s immediate focus will be on resolving the ...

Canaccord Genuity analyst William Maughan maintained a Buy rating and increased the price target from $171 to $171.44 on Nov. 27, 2024. This analyst has an accuracy rate of 71%. JP Morgan analyst ...

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

"Our research shows that PfSnf2L is essential for P. falciparum to dynamically adjust gene expression," explains Maria Theresia Watzlowik, lead author of the study. The unique sequence and ...

A molecular quality-control system in Anopheles mosquitoes—the species responsible for most of the world's malaria cases—is a promising target for ...